Consensus Document for the Selection of Lung Transplant Candidates: An Update from ISHLT
Published 24 July 2021
Lorriana E. Leard, MD; Are M. Holm, MD, PhD; Maryam Valapour, MD, MPP; Allan R. Glanville, MBBS, MD; Sandeep Attawar, MBBS, MS, MCh; Meghan Aversa, MD; Silvia V. Campos, MD; Lillian M. Christon, PhD; Marcelo Cypel, MD, MSc; Göran Dellgren, MD, PhD; Matthew G. Hartwig, MD, MHS; Siddhartha G. Kapnadak, MD; Nicholas A. Kolaitis, MD, MAS; Robert M. Kotloff, MD; Caroline M. Patterson, MD
Oksana A. Shlobin, MD; Patrick J. Smith, PhD, MPH; Amparo Solé, MD, PhD; Melinda Solomon, MD, MSc; David Weill, MD; Marlies S. Wijsenbeek, MD, PhD; Brigitte W.M. Willemse, MD, PhD; Selim M. Arcasoy, MD, MPH; Kathleen J. Ramos, MD, MSc
J Heart Lung Transplant. 2021 Nov; 40(11):1349-1379
Tens of thousands of patients with advanced lung diseases may be eligible to be considered as potential candidates for lung transplant around the world each year. The timing of referral, evaluation, determination of candidacy, and listing of candidates continues to pose challenges and even ethical dilemmas. To address these challenges, the International Society for Heart and Lung Transplantation appointed an international group of members to review the literature, to consider recent advances in the management of advanced lung diseases, and to update prior consensus documents on the selection of lung transplant candidates.
The purpose of this updated consensus document is to assist providers throughout the world who are caring for patients with pulmonary disease to identify potential candidates for lung transplant, to optimize the timing of the referral of these patients to lung transplant centers, and to provide transplant centers with a framework for evaluating and selecting candidates. In addition to addressing general considerations and providing disease specific recommendations for referral and listing, this updated consensus document includes an ethical framework, a recognition of the variability in acceptance of risk between transplant centers, and establishes a system to account for how a combination of risk factors may be taken into consideration in candidate selection for lung transplantation.
Read at JHLTRelated Guidlines
-
Utilization of Hepatitis C Virus–Infected Organ Donors in Cardiothoracic Transplantation
-
EPPVDN Expert Consensus Statement on the Diagnosis and Treatment of Paediatric Pulmonary Hypertension
-
The 2016 ISHLT Listing Criteria for Heart Transplantation: A 10-year Update
-
Present Status of Research on Psychosocial Outcomes in Cardiothoracic Transplantation— Review and Recommendations for the Field
-
ISHLT Consensus Statement on Adult and Pediatric Airway Complications after Lung Transplantation

